Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02306200 · ClinicalTrials.gov registry record

Cardiovascular Health Improvement Project

A clinical trial of Heart Failure and Cardiovascular Diseases, sponsored by University of Michigan.

Recruiting
Registry status
1
Study location

NCT02306200 is a study of Heart Failure and Cardiovascular Diseases that is actively recruiting participants, run by University of Michigan. The registry lists this as an open-ended (no fixed target) study. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02306200, a study of Heart Failure and Cardiovascular Diseases, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
open-ended (no fixed target)
Enrollment target
1
Study location

Study Summary

The goal of this project is to establish a biobank of clinical information, DNA, plasma, and aortic tissue samples from patients with cardiovascular disease as well as healthy controls.

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target open-ended (no fixed target)
Start Date 2013-08
Est. Completion 2053-08

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT02306200

The ClinicalTrials.gov registry entry for NCT02306200 describes a study currently listed as recruiting, categorized as an unspecified phase. The registry lists this as an open-ended (no fixed target) study, common for long-running registries and repositories that collect data indefinitely rather than recruiting toward a fixed participant count. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.

NCT02306200 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT02306200 about?

NCT02306200 is a clinical study titled "Cardiovascular Health Improvement Project". The goal of this project is to establish a biobank of clinical information, DNA, plasma, and aortic tissue samples from patients with cardiovascular disease as well as healthy controls.

What is the current status of trial NCT02306200?

This trial is currently recruiting. The enrollment target is open-ended (no fixed target). The study started on 2013-08. Estimated completion is 2053-08.

What conditions does trial NCT02306200 study?

This clinical trial studies the following conditions: Heart Failure, Cardiovascular Diseases, Aortic Aneurysm, Aortic Dissection, Bicuspid Aortic Valve (BAV).

Who is sponsoring clinical trial NCT02306200?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02306200 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.